jcm-logo

Journal Browser

Journal Browser

Announcements

1 October 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Dermatology” Held on 30 May 2024


The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held an Editorial Board meeting for the Section “Dermatology” on 30 May 2024. We appreciate the Section Editor-in-Chief, Dr. Alan Fleischer, for hosting this meeting; five Editorial Board Members were in attendance.

The meeting started with a presentation about the development of the journal, as well as the Section “Dermatology”in particular and the following information was presented:

  • Journal history, publication statistics, distribution of scholars (2018–2023), the benefits of open access, journal awards, conference sponsorship, webinars, society collaborations, and promotion on social media;
  • Section highly cited papers, article types, graphical abstract/video abstract, geographical distribution of the Section’s Editorial Board Members, Special Issues, and Section statistics.

At this Editorial Board meeting, the EBMs had a positive discussion about submissions’ diversity of country types, Section visibility, journal and Section promotion at relevant conferences, popular topics (such as alopecia, drug development in the field, and the personalized treatment of melanoma), recruitment of Editorial Board Members, etc. The meeting ended with some suggestions from our Editorial Board Members regarding the improvement of our editorial process and suggestions for marketing activities. 

We would like to thank every Editorial Board Member and contributing academic for their support and we look forward to receiving more suggestions so that we can continue our progress together.

Attendee list (in no particular order):

  • Alan Fleischer (Section Editor-in-Chief), University of Cincinnati, Cincinnati, OH, USA;
  • Guy Orchard, St. Thomas’ Hospital, London, UK;
  • Dr. Carlo Pincelli, University of Modena and Reggio Emilia, Modena, Italy;
  • Dr. Marcus Schmitt-Egenolf, Umeå University, Umeå, Sweden;
  • Dr. Reinhart M. Speeckaert, Ghent University Hospital, Ghent, Belgium;
  • Yolanda Gilaberte, University Hospital Miguel Servet, Zaragoza, Spain.

The latest official CiteScore (2023 Scopus data) for the Journal of Clinical Medicine is 5.7, ranking 80/636 (Q1) in the “General Medicine” category. The current Impact Factor of JCM is 3.0 (2023), ranking 58/325 (Q1) in the “Medicine, General & Internal” category.

To access more journal statistics, please click here.

To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Dermatology.

JCM Editorial Office

29 September 2024
MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together


As a leader in open access publishing, MDPI is eager to explore new collaboration opportunities, including the launch of new journals and the transfer of existing ones. At present, MDPI publishes over 400 journals, more than 160 of which have established partnerships with academic organizations. Additionally, we publish 19 association journals.

In order to enhance exchange and cooperation with scientific researchers and share the results of open science, MDPI invites experts and scholars from various fields to submit proposals for new journal collaboration opportunities. If your proposal is approved, you could take on the role of Editor-in-Chief, Deputy Editor-in-Chief, or Editorial Board Member of the journal. This position allows you to manage the manuscript review process alongside our editorial department, participate in calls for papers, strengthen your network with scholars in the field, expand scientific research cooperation, enhance your personal and academic influence internationally, and play a leading role in academia.

Once the new journal is online, MDPI will provide a variety of promotional channels to market the journal internationally.

MDPI will offer various promotional channels to enhance its visibility and promote it internationally.

How can you determine the theme of a new journal?

  • Assess research hotspots/academic frontiers;
  • Assess pioneers in the field/key research directions of universities;
  • Determine whether MDPI has already established a journal in the field.

You can browse MDPI’s existing journals at the following link: https://www.mdpi.com/about/journals.

Advantages of collaborating with MDPI:

  • MDPI is a global leader in open-access publishing with extensive academic resources.
  • MDPI offers a professional publishing team that provides comprehensive support throughout the publishing process.
  • MDPI’s diverse promotional platforms and channels help journals quickly increase their international visibility and influence.

We invite you to submit new journal proposal here, and contribute to academic development! In addition, if your institution (university, institute, college, national key laboratory, society, etc.) intends to establish a journal, you can also submit a draft to MDPI on its behalf.

29 September 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Obstetrics and Gynecology


We are delighted to share some highly cited papers on obstetrics and gynecology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Obstetrics & Gynecology” are currently open for submission.

The following is a list of articles and Special Issues that we believe will interest you:

1. “Evaluating the Efficacy of Pervistop®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study”
by Cesare Aragona, Maria Salomè Bezerra Espinola, Gabriele Bilotta, Giuseppina Porcaro and Marco Calcagno
J. Clin. Med. 2023, 12(6), 2171; https://doi.org/10.3390/jcm12062171
Available online: https://www.mdpi.com/2077-0383/12/6/2171

2. “Non-Pharmacological Pain Management in Labor: A Systematic Review”
by Wassan Nori, Mustafa Ali Kassim Kassim, Zeena Raad Helmi, Alexandru Cosmin Pantazi, Dragos Brezeanu, Ana Maria Brezeanu, Roxana Cleopatra Penciu and Lucian Serbanescu
J. Clin. Med. 2023, 12(23), 7203; https://doi.org/10.3390/jcm12237203
Available online: https://www.mdpi.com/2077-0383/12/23/7203

3. “Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies”
by Aleksandra Szczesnowicz, Anna Szeliga, Olga Niwczyk, Gregory Bala and Blazej Meczekalski
J. Clin. Med. 2023, 12(18), 5915; https://doi.org/10.3390/jcm12185915
Available online: https://www.mdpi.com/2077-0383/12/18/5915

4. “Understanding Psychological Symptoms of Endometriosis from a Research Domain Criteria Perspective”
by Katharina van Stein, Kathrin Schubert, Beate Ditzen and Cornelia Weise
J. Clin. Med. 2023, 12(12), 4056; https://doi.org/10.3390/jcm12124056
Available online: https://www.mdpi.com/2077-0383/12/12/4056

5. “Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System”
by Toobah Farooqi, Deep Jyoti Bhuyan, Mitchell Low, Justin Sinclair, Mathew Leonardi and Mike Armour
J. Clin. Med. 2023, 12(22), 7071; https://doi.org/10.3390/jcm12227071
Available online: https://www.mdpi.com/2077-0383/12/22/7071

6. “Recurrent Pregnancy Loss Etiology, Risk Factors, Diagnosis, and Management. Fresh Look into a Full Box”
by Akbayan Turesheva, Gulzhanat Aimagambetova, Talshyn Ukybassova, Aizada Marat, Perizat Kanabekova, Lyazzat Kaldygulova, Ainur Amanzholkyzy, Svetlana Ryzhkova, Anastassiya Nogay, Zaituna Khamidullina et al.
J. Clin. Med. 2023, 12(12), 4074; https://doi.org/10.3390/jcm12124074
Available online: https://www.mdpi.com/2077-0383/12/12/4074

7. “Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?”
by Anna Maria Rzewuska, Monika Żybowska, Ilona Sajkiewicz, Izabela Spiechowicz, Klaudia Żak, Monika Abramiuk, Krzysztof Kułak and Rafał Tarkowski
J. Clin. Med. 2023, 12(3), 1008; https://doi.org/10.3390/jcm12031008
Available online: https://www.mdpi.com/2077-0383/12/3/1008

8. “Recent Advances in the Prevention and Screening of Preeclampsia”
by Balázs Mészáros, Zoltán Kukor and Sándor Valent
J. Clin. Med. 2023, 12(18), 6020; https://doi.org/10.3390/jcm12186020
Available online: https://www.mdpi.com/2077-0383/12/18/6020

9. “Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review”
by Jaume Alijotas-Reig, Enrique Esteve-Valverde, Ariadna Anunciación-Llunell, Joana Marques-Soares, Josep Pardos-Gea and Francesc Miró-Mur
J. Clin. Med. 2022, 11(3), 675; https://doi.org/10.3390/jcm11030675
Available online: https://www.mdpi.com/2077-0383/11/3/675

10. “PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment”
by Blazej Meczekalski, Olga Niwczyk, Anna Kostrzak, Marzena Maciejewska-Jeske, Gregory Bala and Anna Szeliga
J. Clin. Med. 2023, 12(3), 1221; https://doi.org/10.3390/jcm12031221
Available online: https://www.mdpi.com/2077-0383/12/3/1221

11. “Diaphragmatic Endometriosis—A Single-Center Retrospective Analysis of the Patients’ Demographics, Symptomatology, and Long-Term Treatment Outcomes”
by Antoine Naem, Argyrios Andrikos, Alin Stefan Constantin, Michael Khamou, Dimitrios Andrikos, Antonio Simone Laganà, Rudy Leon De Wilde and Harald Krentel
J. Clin. Med. 2023, 12(20), 6455; https://doi.org/10.3390/jcm12206455
Available online: https://www.mdpi.com/2077-0383/12/20/6455

12. “Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes”
by Angelos Daniilidis, Georgios Grigoriadis, Dimitrios Rafail Kalaitzopoulos, Stefano Angioni, Üzeyir Kalkan, Adrien Crestani, Benjamin Merlot and Horace Roman
J. Clin. Med. 2023, 12(16), 5324; https://doi.org/10.3390/jcm12165324
Available online: https://www.mdpi.com/2077-0383/12/16/5324

13. “Three Types of Endometriosis: Pathogenesis, Diagnosis and Treatment. State of the Art”
by Ludovica Imperiale, Michelle Nisolle, Jean-Christophe Noël and Maxime Fastrez
J. Clin. Med. 2023, 12(3), 994; https://doi.org/10.3390/jcm12030994
Available online: https://www.mdpi.com/2077-0383/12/3/994

14. “Radiofrequency Ablation for Adenomyosis”
by Ioannis Dedes, Georgios Kolovos, Arrigo Fruscalzo, David Toub, Cloé Vaineau, Susanne Lanz, Sara Imboden, Anis Feki and Michael D. Mueller
J. Clin. Med. 2023, 12(9), 3069; https://doi.org/10.3390/jcm12093069
Available online: https://www.mdpi.com/2077-0383/12/9/3069

15. “Concomitant Autoimmunity in Endometriosis Impairs Endometrium–Embryo Crosstalk at the Implantation Site: A Multicenter Case-Control Study”
by Noemi Salmeri, Gianluca Gennarelli, Valeria Stella Vanni, Stefano Ferrari, Alessandro Ruffa, Patrizia Rovere-Querini, Luca Pagliardini, Massimo Candiani and Enrico Papaleo
J. Clin. Med. 2023, 12(10), 3557; https://doi.org/10.3390/jcm12103557
Available online: https://www.mdpi.com/2077-0383/12/10/3557

Special Issues

New Advances in Prenatal Diagnosis and Newborn Screening
Guest Editors: Dr. Zoltan Kozinszky and Dr. Andrea Suranyi
Submission deadline: 28 February 2025

Clinical Risks and Perinatal Outcomes in Pregnancy and Childbirth
Guest Editors: Prof. Dr. Apostolos Mamopoulos and Dr. Ioannis Tsakiridis
Submission deadline: 15 November 2024

Prevention and Treatment for Pelvic and Relative Diseases
Guest Editor: Prof. Dr. Ewa Barcz
Submission deadline: 20 December 2024

Clinical Updates on Maternal Fetal Medicine
Guest Editors: Dr. Misgav Rottenstreich and Prof. Dr. Roberta Granese
Submission deadline: 20 January 2025

New Challenges and Perspectives in Polycystic Ovary Syndrome
Guest Editor: Dr. Jim Parker
Submission deadline: 10 November 2024

Advances in Gynecological Diseases
Guest Editor: Dr. Guglielmo Stabile
Submission deadline: 15 April 2025

You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.

JCM Editorial Office

27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced


MDPI journals frequently grant travel awards to empower junior researchers to showcase their latest research at academic conferences, thereby amplifying their impact within their research fields.

We extend our heartfelt congratulations to the 103 recipients of MDPI's 2023 Travel Awards from different countries and territories for their exceptional presentations. These outstanding individuals were selected by the journal editors based on the strength of their research proposals and the anticipated impact of their presentations at academic conferences. We commend their exceptional contributions and wish them continued success in their academic endeavors.

MDPI will continue to provide support and recognition to the academic community. To learn more about the list of awardees, please visit the following pages:

About MDPI Awards:

To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

27 September 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Nephrology and Urology


We are delighted to share some highly cited papers on nephrology and urology that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Nephrology & Urology” are currently open for submission.

The following is a list of articles and Special Issues that we believe will interest you:

1. “Management of Hypertension in Diabetic Kidney Disease”
by Gates B. Colbert, Mohamed E. Elrggal, Anna Gaddy, Hector M. Madariaga and Edgar V. Lerma
J. Clin. Med. 2023, 12(21), 6868; https://doi.org/10.3390/jcm12216868
Available online: https://www.mdpi.com/2077-0383/12/21/6868

2. “Urethral Injuries: Diagnostic and Management Strategies for Critical Care and Trauma Clinicians”
by Anish B. Patel, E. Charles Osterberg, Praveen N. Satarasinghe, Jessica L. Wenzel, Sabah T. Akbani, Saad L. Sahi, Brent J. Emigh, J. Stuart Wolf, Jr. and Carlos V. R. Brown
J. Clin. Med. 2023, 12(4), 1495; https://doi.org/10.3390/jcm12041495
Available online: https://www.mdpi.com/2077-0383/12/4/1495

3. “A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence”
by Mohit Mathur, Tak Mao Chan, Kook-Hwan Oh, Laura Kooienga, Min Zhuo, Cibele S. Pinto and Bobby Chacko
J. Clin. Med. 2023, 12(21), 6927; https://doi.org/10.3390/jcm12216927
Available online: https://www.mdpi.com/2077-0383/12/21/6927

4. “Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety”
by Peter Schnuelle
J. Clin. Med. 2023, 12(19), 6424; https://doi.org/10.3390/jcm12196424
Available online: https://www.mdpi.com/2077-0383/12/19/6424

5. “Pseudohyponatremia: Mechanism, Diagnosis, Clinical Associations and Management”
by Fahad Aziz, Ramin Sam, Susie Q. Lew, Larry Massie, Madhukar Misra, Maria-Eleni Roumelioti, Christos P. Argyropoulos, Todd S. Ing and Antonios H. Tzamaloukas
J. Clin. Med. 2023, 12(12), 4076; https://doi.org/10.3390/jcm12124076
Available online: https://www.mdpi.com/2077-0383/12/12/4076

6. “Adaptation of the Brain to Hyponatremia and Its Clinical Implications”
by Fabrice Gankam Kengne
J. Clin. Med. 2023, 12(5), 1714; https://doi.org/10.3390/jcm12051714
Available online: https://www.mdpi.com/2077-0383/12/5/1714

7. “Shockwave Lithotripsy for De-Novo Urolithiasis after Kidney Transplantation: A Systematic Review of the Literature”
by Clara Cerrato, Victoria Jahrreiss, Carlotta Nedbal, Francesco Ripa, Vincenzo De Marco, Manoj Monga, Amelia Pietropaolo and Bhaskar Somani
J. Clin. Med. 2023, 12(13), 4389; https://doi.org/10.3390/jcm12134389
Available online: https://www.mdpi.com/2077-0383/12/13/4389

8. “Pathomechanisms of Diabetic Kidney Disease”
by Satyesh K. Sinha and Susanne B. Nicholas
J. Clin. Med. 2023, 12(23), 7349; https://doi.org/10.3390/jcm12237349
Available online: https://www.mdpi.com/2077-0383/12/23/7349

9. “A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors”
by Cheng Ta Han, Md. Mohaimenul Islam, Tahmina Nasrin Poly, Yu-Chun Lu and Ming-Chin Lin
J. Clin. Med. 2023, 12(7), 2467; https://doi.org/10.3390/jcm12072467
Available online: https://www.mdpi.com/2077-0383/12/7/2467

10. “Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?”
by Giovanni Bertoldi, Ilaria Caputo, Giulia Driussi, Lucia Federica Stefanelli, Valentina Di Vico, Gianni Carraro, Federico Nalesso and Lorenzo A. Calò
J. Clin. Med. 2023, 12(5), 2063; https://doi.org/10.3390/jcm12052063
Available online: https://www.mdpi.com/2077-0383/12/5/2063

11. “Nephroprotective Properties of Antidiabetic Drugs”
by Christian Gerdes, Nicolle Müller, Gunter Wolf and Martin Busch
J. Clin. Med. 2023, 12(10), 3377; https://doi.org/10.3390/jcm12103377
Available online: https://www.mdpi.com/2077-0383/12/10/3377

12. “Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies”
by Chieh-Chen Wu, Mao-Hung Liao, Woon-Man Kung and Yao-Chin Wang
J. Clin. Med. 2023, 12(6), 2262; https://doi.org/10.3390/jcm12062262
Available online: https://www.mdpi.com/2077-0383/12/6/2262

13. “Optimizing Outcomes in Flexible Ureteroscopy: A Narrative Review of Suction Techniques”
by Catalina Solano, Marie Chicaud, Stessy Kutchukian, Luigi Candela, Mariela Corrales, Frédéric Panthier, Steeve Doizi and Olivier Traxer
J. Clin. Med. 2023, 12(8), 2815; https://doi.org/10.3390/jcm12082815
Available online: https://www.mdpi.com/2077-0383/12/8/2815

14. “Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin”
by Antonio Lacquaniti, Fabrizio Ceresa, Susanna Campo, Giovanna Barbera, Daniele Caruso, Elenia Palazzo, Francesco Patanè and Paolo Monardo
J. Clin. Med. 2023, 12(16), 5193; https://doi.org/10.3390/jcm12165193
Available online: https://www.mdpi.com/2077-0383/12/16/5193

15. “Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology”
by Tomasz Stompór, Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, Michał Nowicki, Leszek Tylicki, Agata Winiarska and Magdalena Krajewska
J. Clin. Med. 2023, 12(16), 5184; https://doi.org/10.3390/jcm12165184
Available online: https://www.mdpi.com/2077-0383/12/16/5184

Special Issues

Chronic Kidney Disease: Clinical Updates and Perspectives, Opportunities and Challenges
Guest Editor: Dr. Botond Csiky
Submission deadline: 25 October 2024

New Insights into Peritoneal Dialysis and Hemodialysis
Guest Editor: Dr. Grazia Maria Virzì
Submission deadline: 28 November 2024

Renal Failure: Treatment Advances and Future Directions
Guest Editor: Dr. Nada Alachkar
Submission deadline: 20 December 2024

Clinical Perspectives in Reconstructive Urethral Surgery
Guest Editor: Dr. Krishnan Venkatesan
Submission deadline: 30 April 2025

Innovations in Minimally Invasive Surgery (MIS) in Urology
Guest Editors: Dr. Octavian Sabin Tataru, Dr. Roberto Bianchi and Dr. Giuseppe Fallara
Submission deadline: 30 March 2025

Current Advances and Challenges in Urological Surgery Using Laser Technologies
Guest Editors: Dr. Frédéric Panthier and Prof. Dr. Olivier Traxer
Submission deadline: 31 January 2025

You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.

JCM Editorial Office

11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced


MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.

We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.

MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

About MDPI Awards:

To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

10 September 2024
Journal of Clinical Medicine | Special Issue Mentor Program


We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.

This program will enable early career researchers (required to hold a Ph.D. in a related field) to gain experience editing a Special Issue in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) under the mentorship of our experienced Editorial Board Members or other experienced scientists. The program will provide an excellent opportunity for early career scientists to cultivate their ability to edit and process scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and, with the assistance of the mentor, preparing a summary (around 200 words) and 5–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing the invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special issue and quality control of the publications in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions for submissions under the assistance of mentees.

Certificates and Awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and mentees.

If you are interested in this opportunity, please send your Special Issue proposal to the Journal of Clinical Medicine Editorial Office, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue Mentor Program, the Journal of Clinical Medicine will continue to welcome all Special Issue proposals focusing on hot research topics.

JCM Editorial Office

10 September 2024
Meet Us at the GSA 2024 Annual Scientific Meeting (GSA 2024), 13–16 November 2024, Seattle, USA


MDPI will be attending the GSA 2024 Annual Scientific Meeting (GSA 2024), which will be held from 13 to 16 of November 2024, in Seattle, USA.

The Gerontological Society of America (GSA) Annual Scientific Meeting draws professionals in the field of aging on a global scale, representing specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, and psychology. The GSA is the largest and most established international, interdisciplinary scientific organization devoted to the advancement of gerontological research.

GSA 2024 offers numerous opportunities for career development and networking. Nearly 4,000 researchers, clinicians, educators, and other professionals will gather in Seattle to learn about and discuss the latest trends, research, and key issues in aging.

The following MDPI journals will be represented at the conference:

If you are planning to attend the conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries you may have. For more information about the conference, please visit the official website at https://www.gsa2024.org/.

4 September 2024
Meet Us at the 30th Annual Meeting of Japanese Society for Hemodiafiltration, 2–3 November 2024, Nagasaki, Japan


Conference: The 30th Annual Meeting of Japanese Society for Hemodiafiltration
Date: 2–3 November 2024
Location:
Nagasaki, Japan

MDPI will be attending the 30th Annual Meeting of Japanese Society for Hemodiafiltration as an exhibitor, and we are welcoming researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the Japanese Society for Hemodiafiltration. The Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry (JRDR) was established in 1968. The society has a long history and more than 1000 members. The event being organized in Nagasaki in 2024 is estimated to have around 1000 attendees.

The following MDPI journals will be represented:

If you are planning on attending this conference, please do not hesitate to contact us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.congre.co.jp/hdf2024/index.html.

3 September 2024
MDPI INSIGHTS: The CEO's Letter #15 - CHORUS, Best Paper Award, August Events

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

I am pleased to share that MDPI is now an Affiliate Member of CHORUS, a not-for-profit organization dedicated to ensuring public access to articles reporting on U.S. government-funded research. This partnership highlights our long-standing commitment to advancing Open Access (OA) publishing and meeting funders’ open research requirements.

Read the full announcement here.

With the White House Office of Science and Technology Policy (OSTP) 2022 memorandum calling for immediate public access to all federally funded research by 2026, this partnership positions MDPI to further support academic institutions in adhering to national mandates while providing authors with fully compliant (CC-BY) OA journals.

The CHORUS platform went live in July 2014 and includes NASA, the U.S. Department of Energy, the U.S. Department of Defense, the U.S. Geological Survey, and the National Science Foundation.

“This partnership positions MDPI to further support academic institutions in adhering to national mandates”

Joining CHORUS perfectly aligns our mission as the leading OA publisher, which is to drive transparency and innovation in scholarly publishing, with that of CHORUS itself, which is to advance Open Access research. It will also support MDPI publications from organizations such as NASA, with 1,200 research papers published by NASA-affiliated authors as at 31 August 2024.

Impactful Research

MDPI’s Best Paper Awards—Award-Winning Papers in 2023 Announced

MDPI is committed to supporting and recognizing the academic community and is proud to announce the recipients of the 2023 Best Paper Awards, which recognize high-quality papers of significant scientific merit and impact. Each year, the editors of our journals carefully select papers that showcase outstanding scientific achievement.

This year, 115 Best Paper Awards were presented, chosen from 346 exceptional papers in a highly competitive selection process. Congratulations to the authors for their remarkable contributions!

To learn more about all the awardees and their research projects, visit the following pages:

About MDPI Awards
MDPI regularly offers various awards to recognize researchers, particularly young scientists, and to promote communication within the scientific community. These awards exist to inspire and acknowledge talented scientists who have made significant contributions to advancing their fields.

To find out more MDPI awards, please click here.

“Our awards exist to inspire and acknowledge talented scientists”

Inside MDPI

MDPI AI Team Presented at EuroSciPy 2024 in Poland

As part of the CEO Letter, I hold dear this ‘Inside MDPI’ section, where I have an opportunity to highlight various projects, teams and updates within our organization. As such, I’m happy to showcase the following presentations from members of MDPI’s Artificial Intelligence (AI) team, which were recently presented at the EuroSciPy 2024 (16th European Conference on Python in Science). This conference took place in Szczecin, Poland from 26–30 August.

“This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing”

MDPI colleagues Frank Sauerburger (AI Tech Leader) and Daniele Raimondi (Senior Data Scientist) both presented at the conference. Frank discussed MDPI’s AI infrastructure, while Daniele showcased a new methodological approach we have been developing to track the journey of rejected academic manuscripts. This approach combines AI, data science and analytics to improve the identification of manuscripts and authors, enhancing our understanding of publishing dynamics.

This event was a great opportunity to reinforce our commitment to innovation and excellence in publishing. It also allowed us to contribute to the academic discussion on integrating AI and data science into scholarly communication.

From data analysis in Jupyter Notebooks to production applications: AI infrastructure at reasonable scale – Frank Sauerburger

Frank’s presentation on MDPI’s AI infrastructure provided a chance to showcase the advanced technological frameworks that power our operations. Given the technical and academic focus of EuroSciPy, this talk demonstrated how MDPI’s AI capabilities are not only cutting-edge but also central to driving efficiency and innovation in scholarly publishing. Engaging with the EuroSciPy community helps position MDPI as a leader in applying AI within the publishing industry, fostering potential collaborations and attracting interest from top researchers.

A Qdrant and Specter2 framework for tracking resubmissions of rejected manuscripts in academia – Daniele Raimondi

Daniele’s talk on the novel methodological approach that combines AI, Data Science, and Analytics was crucial in highlighting how MDPI is advancing the precision and effectiveness of manuscript and author identification. This approach is pivotal in enhancing our understanding of publishing dynamics and ensuring the quality and integrity of the academic content we manage. By presenting at EuroSciPy, we had the opportunity to engage with an audience deeply involved in scientific computing, gaining feedback and insights that could further refine our methodologies.

Thank you, Frank and Daniele, for representing MDPI so well!

I will share more about MDPI’s AI team and projects in upcoming CEO Letters, as we have a well-rounded AI and Data Team working on an exciting suite of AI products for MDPI and the scholarly community at large.

Coming Together for Science

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science

I am pleased to share the success of our MDPI conference The 1st International Conference on Artificial Intelligence (AI) Sensors and the 10th International Symposium on Sensor Science in Singapore this past 1–4 August.

With nearly 400 attendees, the event brought together researchers and industry experts from China, Singapore, Japan, Korea, Taiwan, India and other countries to share their findings on the latest developments in sensors, sensing technology, artificial intelligence for sensing applications and AI-enhanced sensing systems.

We accepted a total of 355 abstracts, featuring 772 authors from 28 countries. Over the course of the four-day event, 66 posters were displayed and 296 talks were delivered, including 4 plenary talks, 46 keynote speeches, 122 invited talks, and 124 selected oral presentations. View the event gallery here.

I am pleased to announce the winners of the four awards, including Best Presentation and Best Poster, recognizing the contributions of our participants during the conference.

Looking ahead, the 2nd International Conference on AI Sensors and Transducers is scheduled to take place from 29 July to 5 August, 2025, in Bangkok, Thailand.

Thank you to our Conference team, including Ionut Spatar, Teodora Nicoleta Cremene, Ang Kai Lin, Benjamin Tay, Leong Jin Yue Esther, Wong Jolin, Judith Wu, Alethea Liu and Flora Li, who were involved in making this event a success. A big thank-you also goes to our local MDPI colleagues for their support: Yu Nwe Soe, Hen Chu Yang, Kwah Zhi En Watcharapong, Zephan Yang, Daphne Neo, Huimin Cheng, Nathan Li and Ting Yin.

Upcoming In-Person Event

25–27 September, 2024
The 5th International Conference on Materials: Advances in Material Innovation
Location: Basel, Switzerland

ICM 2024 will unite experts to share insights on recent advancements in Materials Characterization, Processing and Manufacturing.

7–9 October, 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland

ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.

Find more upcoming MDPI events here.

Closing Thoughts

The 2nd Sustainable Publishing Forum

In 2022, the International Association of Scientific, Technical and Medical Publishers (STM) outlined three goals to reflect the academic community’s shared aspirations: promoting Open Science, maintaining research integrity and fulfilling social responsibility. Open Science has evolved from the Open Access movement of the early 2000s to become a preferred model in academic publishing. Publishers and academic journals play a crucial role in ensuring research integrity, with efforts to prevent misconduct markedly on the increase now.

As the world faces sustainability challenges, the academic publishing industry is increasingly committed to contributing the achievement of the United Nations Sustainable Development Goals (SDGs). Many publishers are implementing strategies to support these objectives, including ours, which you can view here.

The 2nd MDPI Sustainable Publishing Forum provided a platform for global editors and publishers to discuss these themes, aiming to strengthen collaboration and advance the contributions that scientific publishing can make to academia and society.

“Open Science has evolved to become a preferred model in academic publishing”

The 2nd Sustainable Publishing Forum

We hosted MDPI’s 2nd Sustainable Publishing Forum in Beijing, China, on 15–16 August, attracting nearly 120 attendees from local and international publishers, university presses, scientific and technical journal associations, libraries and the Chinese Academy of Sciences. The event focused on promoting Open Science, maintaining research integrity, and fulfilling social responsibility.

This was an excellent opportunity for us to share more with conference attendees about the approach of our research integrity team. Our Head of Publishing, Peter Roth, also participated, speaking on how to identify and avoid predatory publishers and about the principles that underpin ethical academic publishing.

I extend my thanks to all of our conference speakers, including Hylke Koers (STM Solutions), who presented on STM Trends 2028 and shared insights on the STM Integrity Hub, of which MDPI is a member.

Stefan Tochev
Chief Executive Officer
MDPI AG

Back to TopTop